HODGKIN'S DISEASE NODULAR SCLEROSIS STAGE UNSPECIFIED

This adverse event was reported 38 times

These drugs are most commonly taken by patients reporting HODGKIN'S DISEASE NODULAR SCLEROSIS STAGE UNSPECIFIED:

# Drug Count
0 INFLIXIMAB 12
1 METHOTREXATE 8
2 METHOTREXATE SODIUM 8
3 AZATHIOPRINE 6
4 PREDNISONE 6
5 BLEOMYCIN SULFATE 5
6 PREDNISOLONE 5
7 PREDNISOLONE ORAL 5
8 PREDNISOLONE ORAL SOLUTION 5
9 DACARBAZINE 4
See all common drugs associated with HODGKIN'S DISEASE NODULAR SCLEROSIS STAGE UNSPECIFIED

HODGKIN'S DISEASE NODULAR SCLEROSIS STAGE UNSPECIFIED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ACYCLOVIR SODIUM 1 0.0008
1 DACARBAZINE 4 0.0005
2 VINBLASTINE SULFATE 1 0.0005
3 BLEOMYCIN SULFATE 5 0.0005
4 AZATHIOPRINE SODIUM 1 0.0004
5 MESNA INJECTION 1 0.0001
6 MESNA 1 0.0001
7 MESALAMINE 3 0.0001
8 BRENTUXIMAB VEDOTIN 1 0.0001
9 ZONISAMIDE 1 0.0001
See all drugs enriched for association with HODGKIN'S DISEASE NODULAR SCLEROSIS STAGE UNSPECIFIED

HODGKIN'S DISEASE NODULAR SCLEROSIS STAGE UNSPECIFIED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD30-directed Immunoconjugate [EPC] 1 0.0001
1 Purine Antimetabolite [EPC] 6 0.0001
2 Topoisomerase Inhibitor [EPC] 3 0.0000
3 Provitamin D2 Compound [EPC] 1 0.0000
4 Aminosalicylate [EPC] 3 0.0000
5 Protease Inhibitor [EPC] 1 0.0000
6 Alkylating Drug [EPC] 5 0.0000
7 Folate Analog Metabolic Inhibitor [EPC] 8 0.0000
8 Cytochrome P450 3A Inhibitor [EPC] 1 0.0000
9 Cholinergic Nicotinic Agonist [EPC] 1 0.0000
See all drug classes enriched for association with HODGKIN'S DISEASE NODULAR SCLEROSIS STAGE UNSPECIFIED